News Karnataka
Sunday, April 21 2024
Cricket
Delhi

Biological E gets DCGI nod to conduct phase 2/3 trials on children

Biological E Gets Dcgi Nod To Conduct Phase
Photo Credit :

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children. The trial will be on children between 5 and 18 years of age with certain conditions.

The permission was given on Wednesday after the recommendation from the Subject Expert Committee.

The trial will be conducted in ten locations across the country.

The government has made an advance payment of Rs 1,500 crore to Biological E for the 30 crore vaccines.

Meanwhile, the trials of Bharat Biotech’s Covaxin Covid-19 vaccine for phases 2 and 3 for children are underway, and its result is expected in September.

The Zydus Cadila’s needle-free Covid-19 vaccine ZyCoV-D has already received emergency use authorisation (EUA) to inoculate children in the age group of 12-18. It is expected to be administered from the first week of October.

Meanwhile, the data of phase 2/3 clinical trials of Bharat Biotech’s Covaxin in the age group 2 to 18 years is underway.

India reported 47,029 coronavirus cases and 509 deaths in the last 24 hours. With this the country’s overall caseload rose to 3.28 crore (3,28,57,937) and the death toll increased to 4.39 lakh (4,39,529).

 

Share this:
MANY DROPS MAKE AN OCEAN
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

To get the latest news on WhatsApp